How much does a box of Larotrectinib cost and price comparison in different regions

Larotrectinib (trade name Vitrakvi®) is now officially launched in China for the treatment of NTRK fusion-positive solid tumors. Unlike many imported targeted drugs, larotrectinib has been included in my country's medical insurance directory, which means that eligible patients can enjoy a certain percentage of reimbursement when purchasing it in the hospital, thus significantly reducing the financial burden. Patients still need to undergo NTRK fusion gene testing through a regular hospital before use to confirm the indications.

In the domestic market, the price of the original drug larotrectinib is relatively high, about about 20,000 yuan per box. The specific reimbursement ratio and payment method will vary depending on local medical insurance policies, hospital levels, and patient medical insurance types. Therefore, patients should consult the local medical insurance policy with the hospital pharmacy before purchasing drugs to understand the actual out-of-pocket expenses and reimbursement process.

In overseas markets, the original drug of larotrectinib is more expensive, and for patients with limited financial conditions, some countries and regions have launched generic versions of larotrectinib. Larotinib generics have been launched. For example, the price of the Laos version of generic drugs is only a few hundred yuan to more than a thousand yuan, which is dozens of times cheaper than the original drug. Although the price is low, the active ingredients of these generic drugs are basically the same as those of the original drugs, and the efficacy can reach a similar level. However, formal channels must be selected when purchasing to ensure drug quality and safety.

Patients who purchase larotrectinib in China should give priority to purchasing larotrectinib through regular hospitals or medical insurance designated pharmacies to enjoy medical insurance reimbursement and quality assurance. If you are considering overseas generic drugs, it is recommended to purchase them through a qualified cross-border pharmacy or medical service platform to avoid affecting the treatment effect due to counterfeit drugs or irregular channels. At the same time, the dosage, course of treatment, and possible adverse reactions should be confirmed according to the guidance of a doctor before use to ensure safe and effective completion of treatment.

Reference link:https://www.drugs.com

xa0